Norges Bank’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-131,966
Closed -$962K 1886
2023
Q4
$962K Sell
131,966
-122,132
-48% -$963K ﹤0.01% 1870
2023
Q3
$2.31M Sell
254,098
-287,945
-53% -$3.45M ﹤0.01% 1813
2023
Q2
$6.6M Buy
542,043
+132,000
+32% +$1.47M ﹤0.01% 1653
2023
Q1
$5.1M Sell
410,043
-165,251
-29% -$3.04M ﹤0.01% 1750
2022
Q4
$11.1M Hold
575,294
﹤0.01% 1535
2022
Q3
$10.8M Buy
575,294
+239,714
+71% +$4.93M ﹤0.01% 1505
2022
Q2
$6.05M Buy
335,580
+13,059
+4% +$212K ﹤0.01% 1723
2022
Q1
$5.17M Sell
322,521
-158,562
-33% -$2.85M ﹤0.01% 1862
2021
Q4
$11.8M Buy
481,083
+213,696
+80% +$5.02M ﹤0.01% 1702
2021
Q3
$6.23M Buy
267,387
+147,361
+123% +$3.56M ﹤0.01% 1893
2021
Q2
$3.29M Buy
120,026
+49,645
+71% +$1.42M ﹤0.01% 1953
2021
Q1
$2.59M Buy
+70,381
New +$2.49M ﹤0.01% 1978

Other funds holding AHCO

Norges Bank's AHCO Position: Q1 2024 in Review

Norges Bank sold out of AdaptHealth (AHCO) in Q1 2024, closing a stake of 131,966 shares — an estimated $962K sold.

Norges Bank first reported a position in AHCO in Q1 2021 and held it in 12 quarters. The position peaked at $11.8M in Q4 2021. 210 funds tracked by Wall St. Rank hold AHCO as of Q1 2024.

  • Norges Bank reported no remaining AdaptHealth position as of Q1 2024 after selling out during the quarter.
  • Norges Bank sold 131,966 AdaptHealth shares in Q1 2024, an estimated $962K.
  • Norges Bank first reported a position in AdaptHealth in Q1 2021 and held it in 12 quarters.
  • Norges Bank's AdaptHealth position peaked at $11.8M in Q4 2021.
  • 210 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2024.

Based on Norges Bank's 13F filing for Q1 2024, filed 14 May 2024.